BTN2A1: A Novel Target to Boost Tumor Killing Capacity of Human γδ T Cells.
Sign Up to like & getrecommendations! Published in 2024 at "Cancer immunology research"
DOI: 10.1158/2326-6066.cir-24-0925
Abstract: γδ T cells have recently raised great interest as effector cells in cancer immunotherapy because of their HLA-independent mode of action and their broad tumor reactivity. To translate the application of γδ T cells into… read more here.
Keywords: tumor killing; btn2a1 novel; target boost; tumor ... See more keywords